Centrecourt AB

About The Fund

Centrecourt AB is a Stockholm-based venture capital firm engaging in the creation and development of companies with the potential for profitable growth. They operate by investing through separate interest companies and take an active role in collaboration with company management and owners to foster business development. Their drive is to see businesses and individuals flourish. With a special focus on seed, startup, and early-stage investments, Centrecourt leverages its expertise in equity to contribute to the growth and success of innovative ventures. The firm's portfolio showcases a range of diverse companies such as BioGaia, a world leader in health supplements with probiotics; Cavidi, Sweden's premier provider of HIV virus monitoring systems; Nexar, which focuses on talent shows and artist management; and Hemverket, a modern real estate broker that revolutionizes the selling process. Additionally, they have invested in and advised companies like Compodium (secure and reliable video conferencing), CellaVision (blood analysis based on advanced image processing), Prolight Diagnostics (patient-near diagnostic systems), and Precio Fishbone (customized IT solutions based on Microsoft technology). The firm was instrumental in the development of these companies, often taking on advisory roles and helping with business plans and financial strategies. Their team consists of experienced entrepreneurs and professionals with a range of skills in finance, business development, and industry understanding. Centrecourt AB continues to support their ventures with financing solutions and strategic guidance, emphasizing a genuine interest in the long-term success of their investments.